Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advance Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011833
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and respiratory products. It also offers alcohol wet wipes, mouth rinse mint flavors, adult diapers, soaps, multi purpose kitchen cleaner, hand wash lotions, hand wash lotions, and glycerin, among others. APC conducts research and development for the manufacturing, design, marketing, sales, logistics and distribution. The company provides products for various diseases such as cold and flu, analgesic and antipyretic, indigestion, respiratory, and dermatological. It markets products to local dispensaries, medicine shops, clinics, hospitals and chain stores. APC is headquartered in Hong Kong.

Advance Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Boston Therapeutics Expands Licensing Agreement with Advance Pharma for SugarDown 10
Licensing Agreements 11
Boston Therapeutics Expands Licensing Agreement with Advance Pharma 11
Boston Therapeutics Enters Into Licensing Agreement With Advance Pharma For SUGARDOWN 12
Equity Offering 13
Boston Therapeutics Completes Private Placement Of Shares For US$0.5 Million 13
Advance Pharmaceutical Co Ltd – Key Competitors 14
Advance Pharmaceutical Co Ltd – Key Employees 15
Advance Pharmaceutical Co Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advance Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Boston Therapeutics Expands Licensing Agreement with Advance Pharma for SugarDown 10
Boston Therapeutics Expands Licensing Agreement with Advance Pharma 11
Boston Therapeutics Enters Into Licensing Agreement With Advance Pharma For SUGARDOWN 12
Boston Therapeutics Completes Private Placement Of Shares For US$0.5 Million 13
Advance Pharmaceutical Co Ltd, Key Competitors 14
Advance Pharmaceutical Co Ltd, Key Employees 15

★海外企業調査レポート[Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Urologix Inc. (ULGX):企業概要、財務及び戦略的SWOT分析
    Summary Urologix Inc. (Urologix) is a healthcare company. The company develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. Its services include treatment options, cooled thermotherapy, P …
  • ContiTech AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ContiTech AG Mergers and Acquis …
  • Deutsche Post AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Deutsche Post AG Mergers and Ac …
  • Escalon Medical Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Escalon Medical Corp. Mergers a …
  • Medical & Biological Laboratories Co Ltd (4557):企業のM&A・提携動向(医療分野)
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a biotechnology company that develops and manufactures clinical diagnostics and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents fo …
  • Empresa Distribuidora y Comercializadora Norte S.A. (EDN):企業のM&A・提携動向(エネルギー分野)
    Summary Empresa Distribuidora y Comercializadora Norte S.A. (Edenor), a subsidiary of Pampa Energia SA, distributes and sells electricity in Argentina. The company distributes electricity under concession agreement in the northwestern zone of the greater Buenos Aires metropolitan area and in the nor …
  • Compass Group PLC:企業の戦略・SWOT・財務分析
    SummaryCompass Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • VITA 34 International AG (V3V):企業財務及び戦略的SWOT分析
    Summary Vita 34 International AG (Vita 34) is a biotechnology company that offers umbilical cord blood banking services. The company collects, prepares, processes, deposits, and stores stem cells from umbilical cord blood. Its products include vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vi …
  • Consol Energy Inc. (CNX):企業のM&A・提携動向(石油・ガス分野)
    Summary CONSOL Energy Inc. (CONSOL Energy) is a diversified energy company that produces natural gas and coal. It carries out coal bed methane extraction, conventional and shale gas exploration and production. The company produces Shallow oil and gas, Upper Devonian, Chattanooga, and Huron shale; an …
  • Akers Biosciences, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Akers Biosciences, Inc. Mergers …
  • GP Strategies Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' GP Strategies Corporation Merge …
  • JD Sports Fashion Plc:企業のM&A・提携・投資分析
    JD Sports Fashion Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JD Sports Fashion Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Alent Plc:企業の戦略・SWOT・財務分析
    SummaryAlent Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …
  • Richfield Oil & Gas Company(石油・ガス分野):企業M&A動向
    Summary Richfield Oil & Gas Company (ROIL) is an oil and gas company. It undertakes exploration and production of oil and natural gas. The company focuses on acquiring, retrofitting and selling of oil and natural gas. The company’s operating geographical areas are Mid-Continent, Utah-Wyoming Overthr …
  • AutoGenomics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' AutoGenomics, Inc. Mergers and …
  • Metallica Minerals Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Metallica Minerals Ltd. Mergers …
  • Solution Corner (1998) PCL (SLC):企業概要、財務及び戦略的SWOT分析
    Summary Solution Corner (1998) PCL (Solution Corner) is an information technology company. The company develops, installs and distributes software systems and applications. Solution Corner software products include office automation system, enterprise resource management and tools. The company offer …
  • Power Machines:企業のM&A・提携動向(発電分野)
    Summary Power Machines is a power engineering company that designs, manufactures and delivers equipment for thermal, nuclear, hydraulic and gas turbine power plants. The company offers steam, gas and hydraulic turbines, turbogenerators, hydraulic generators, blades for steam and gas turbines and exc …
  • Banca del Mezzogiorno – MedioCredito Centrale SpA.:企業のM&A・提携動向(発電分野)
    Summary Banca del Mezzogiorno - MedioCredito Centrale SpA. (Banca del Mezzogiorno), a subsidiary of Poste Italiane Group is a financial service provider that offers banking services. The company provides financial solutions and services. Its activities include industrial and agricultural credit and …
  • SK hynix, Inc. (formerly Hynix Semiconductor, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SK hynix, Inc. (formerly Hynix …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆